Education
About Us
Working with TipRanks
Follow Us
Daré Bioscience Inc (DARE)
NASDAQ:DARE
Total Valuation
Daré Bioscience has a market cap or net worth of $24.40M. The enterprise value is $24.27M.
Market Cap$24.40M
Enterprise Value$24.27M
Share Statistics
Daré Bioscience has 13,479,502 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,479,502
Owned by Insiders7.89%
Owned by Institutions1.86%
Financial Efficiency
Daré Bioscience’s return on equity (ROE) is 0.67 and return on invested capital (ROIC) is -2253.31%.
Return on Equity (ROE)0.67
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-2253.31%
Return on Capital Employed (ROCE)-47.65
Revenue Per Employee465.90
Profits Per Employee-193.03K
Employee Count21
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Daré Bioscience is ―. Daré Bioscience’s PEG ratio is 0.07.
PE Ratio―
PS Ratio2709.59
PB Ratio-4.41
Price to Fair Value-4.41
Price to FCF5.50
Price to Operating Cash Flow-3.41
PEG Ratio0.07
Income Statement
In the last 12 months, Daré Bioscience had revenue of 9.78K and earned -4.05M in profits. Earnings per share was -0.48.
Revenue9.78K
Gross Profit-14.30M
Operating Income-23.45M
Pretax Income-4.05M
Net Income-4.05M
EBITDA-23.41M
Earnings Per Share (EPS)-0.48
Cash Flow
In the last 12 months, operating cash flow was -6.10M and capital expenditures -741.49K, giving a free cash flow of -6.85M billion.
Operating Cash Flow-6.10M
Free Cash Flow-6.85M
Free Cash Flow per Share-0.51
Dividends & Yields
Daré Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.98
52-Week Price Change-47.17%
50-Day Moving Average2.01
200-Day Moving Average2.55
Relative Strength Index (RSI)33.91
Average Volume (3m)170.74K
Important Dates
Daré Bioscience upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
Daré Bioscience as a current ratio of 0.85, with Debt / Equity ratio of 102.61%
Current Ratio0.85
Quick Ratio0.85
Debt to Market Cap0.00
Net Debt to EBITDA0.61
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Daré Bioscience has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Daré Bioscience EV to EBITDA ratio is -0.52, with an EV/FCF ratio of 2.51.
EV to Sales1.24K
EV to EBITDA-0.52
EV to Free Cash Flow2.51
EV to Operating Cash Flow2.25
Balance Sheet
Daré Bioscience has $23.08M in cash and marketable securities with $2.93M in debt, giving a net cash position of $20.14M billion.
Cash & Marketable Securities$23.08M
Total Debt$2.93M
Net Cash$20.14M
Net Cash Per Share$1.49
Tangible Book Value Per Share-$0.71
Margins
Gross margin is 29020.32%, with operating margin of -239692.20%, and net profit margin of -41430.90%.
Gross Margin29020.32%
Operating Margin-239692.20%
Pretax Margin-41430.90%
Net Profit Margin-41430.90%
EBITDA Margin-239259.61%
EBIT Margin-239692.20%
Analyst Forecast
The average price target for Daré Bioscience is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside495.24% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―